Back to mobile site

Baird Reiterates Outperform Rating on Alto Neuroscience (ANRO)

September 10, 2024 6:30 AM EDT Send to a Friend
Baird analyst Brian Skorney reiterated an Outperform rating and $32.00 price target on Alto Neuroscience (NYSE: ANRO).The analyst commented: "Incrementally ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login